Feb 27, 2019 4:05pm EST OPKO Health Reports 2018 Fourth Quarter Business Highlights and Financial Results
Feb 26, 2019 8:00am EST OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019
Feb 05, 2019 8:30am EST OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes
Feb 01, 2019 8:00am EST OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer
Jan 31, 2019 9:15pm EST OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator
Jan 07, 2019 6:00am EST OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories
Dec 27, 2018 4:34pm EST OPKO Health and OPKO's CEO and Chairman, Dr. Phillip Frost, Announce Proposed Resolution of SEC Action